Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate.
Bateman
E A L
EA
Ardern-Jones
M
M
Ogg
G S
GS
D000328:Adult; D000485:Allergens; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D015234:HLA-A Antigens / Q000235:genetics; D059811:HLA-DRB1 Chains; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D013601:T-Lymphocytes / Q000187:drug effects*
D000485:Allergens; D003879:Dermatologic Agents; D015234:HLA-A Antigens; D059811:HLA-DRB1 Chains; C487961:HLA-DRB1*01:01 antigen; D008727:Methotrexate